Appetite Loss clinical trials at UCLA
1 research study open to eligible people
Showing trials for
AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
open to eligible people ages 21-55
This study will assess the analgesic, appetite-stimulating, and subjective effects of cannabigerol (CBG) alone and in combination with THC.
Los Angeles, California
Our lead scientists for Appetite Loss research studies include Ziva D Cooper, PhD.
Last updated: